TG Therapeutics, Inc. (TGTX)
31.37
-0.63
(-1.97%)
USD |
NASDAQ |
Dec 12, 12:47
TG Therapeutics Research and Development Expense (TTM): 142.90M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Karyopharm Therapeutics, Inc. | 130.89M |
| Axsome Therapeutics, Inc. | 188.68M |
| Krystal Biotech, Inc. | 55.37M |
| Arcutis Biotherapeutics, Inc. | 71.08M |